Back to search

Article

FCGR3A polymorphism : It is helpful for the management of diffuse large B-cell lymphoma

2024-09-02

Abstract excerpt

<title>Abstract</title> <p>Fc receptors (FcRs) polymorphisms may affect the affinity of rituximab for antibody-dependent cellular cytotoxicity (ADCC) effector cells. The C1qA polymorphism may influence C1q levels, but their significance in treatment response and survival is unknown. This study evaluated the role of FCGR3A, C1qA, and HLA-G polymorphisms in the outcomes of patients with diffuse large B cell lymphom...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c0cf29a-d536-5e68-b6ef-b26f8bf51846
DOI
10.21203/rs.3.rs-4797996/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
FCGR3A polymorphism : It is helpful for the management of diffuse large B-cell lymphomaDOI 10.21203/rs.3.rs-4797996/v1
FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma.Semantic proximity
FCGR3A/2A polymorphisms and diffuse large B-cell lymphoma outcome treated with immunochemotherapy: a meta-analysis on 1134 patients from two prospective cohorts.Semantic proximity
The Effect of FcγRIIIA Gene Polymorphism on the Treatment of Diffuse Large B-cell Non-Hodgkin Lymphoma: A Multicenter Prospective Observational Study.Semantic proximity
Fc-gamma-receptor IIIa polymorphism and gene expression profile do not predict the prognosis in diffuse large B-cell lymphoma treated with R-CHOP protocol.Semantic proximity
Fcgamma receptor IIIA polymorphisms and efficacy of rituximab therapy on Chinese diffuse large B-cell lymphoma.Semantic proximity
Correlation of FcγRIIIa Polymorphisms to the Response of Rituximab in Thai Patients with Diffuse Large B-Cell Lymphoma.Semantic proximity
Comprehensive genetic and functional analysis of FcγRs in rituximab therapy for autoimmunity reveals a key role for FcγRIIIa on NK cellsSemantic proximity
FCGR3A 158V/F polymorphism and response to frontline R-CHOP therapy in diffuse large B-cell lymphoma.Semantic proximity
The FCGR3A polymorphism predicts the response to rituximab-based therapy in patients with non-Hodgkin lymphoma: a meta-analysis.Semantic proximity
Effect of FCGR2A and FCGR3A variants on CLL outcome.Semantic proximity
[Efficacy of rituximab therapy on diffuse large B-cell lymphoma with different Fcgamma RIIIA gene polymorphisms: a prospective study].Semantic proximity
Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma.Semantic proximity
Select a neighboring publication to make it the new centre.